NeuroAIDS, drug abuse, and inflammation: building collaborative research activities (Q23915009)

HELD

1 reference

25 September 2023

0 references

0 references

neurological disorder

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

viral infectious disease

1 reference

29 March 2020

1 reference

1 reference

13

0 references

Jau-Shyong Hong

Jau-Shyong Hong

10

0 references

Diane B. Miller

15

Diane B. Miller

0 references

Linda Chang

3

Linda Chang

0 references

James P. O'Callaghan

17

James P. O’Callaghan

0 references

author name string

Joan W. Berman

1

0 references

Monica J. Carson

2

0 references

Brian M. Cox

4

0 references

Howard S. Fox

5

0 references

R. Gilberto Gonzalez

6

0 references

Glen R. Hanson

7

0 references

Kurt F. Hauser

8

0 references

Wen-Zhe Ho

9

0 references

Eugene O. Major

11

0 references

William F. Maragos

12

0 references

Justin C. McArthur

14

0 references

Avindra Nath

16

0 references

Yuri Persidsky

18

0 references

Christopher Power

19

0 references

Thomas J. Rogers

20

0 references

Walter Royal

Journal of Neuroimmune Pharmacology

21

0 references

language of work or name

1 reference

8 November 2006

0 references

published in

0 references

volume

1

0 references

issue

4

0 references

page(s)

351-399

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

1 reference

2 February 2024

https://scigraph.springernature.com/pub.10.1007/s11481-006-9048-9

0 references

cites work

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-006-9048-9

Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization

21 January 2018

1 reference

12 December 2020

Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor

1 reference

12 December 2020

Human immunodeficiency virus-1 protein tat and methamphetamine interactions

1 reference

12 December 2020

μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication

1 reference

12 December 2020

Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.

1 reference

12 December 2020

Effects of morphine on purified human blood monocytes. Modifications of properties involved in antiviral defences

1 reference

12 December 2020

Enhanced replication of simian immunodeficiency virus adjacent to catecholaminergic varicosities in primate lymph nodes.

1 reference

12 December 2020

Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain

1 reference

12 December 2020

Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

1 reference

12 December 2020

Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)

1 reference

12 December 2020

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

1 reference

12 December 2020

Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine

1 reference

12 December 2020

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

1 reference

12 December 2020

3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.

1 reference

12 December 2020

HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS

1 reference

12 December 2020

Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry

1 reference

12 December 2020

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells

1 reference

12 December 2020

Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells

1 reference

12 December 2020

Social stress results in altered glucocorticoid regulation and shorter survival in simian acquired immune deficiency syndrome

1 reference

12 December 2020

CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates

1 reference

12 December 2020

Molecular targets of opiate drug abuse in neuroAIDS.

1 reference

12 December 2020

NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation

1 reference

12 December 2020

The amazing astrocyte.

1 reference

12 December 2020

Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha1

1 reference

12 December 2020

Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications

1 reference

12 December 2020

Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin.

1 reference

12 December 2020

Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats.

1 reference

12 December 2020

Selective neuronal vulnerability in HIV encephalitis

1 reference

12 December 2020

The hypothalamus-pituitary-adrenal axis in HIV disease

1 reference

12 December 2020

Is interferon-alpha a neuromodulator?

1 reference

12 December 2020

Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.

1 reference

12 December 2020

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

1 reference

12 December 2020

Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo

1 reference

12 December 2020

Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

1 reference

12 December 2020

Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesis

1 reference

12 December 2020

Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells.

1 reference

12 December 2020

Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes

1 reference

12 December 2020

Role of monoamine transporters in mediating psychostimulant effects

1 reference

12 December 2020

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

12 December 2020

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function

1 reference

12 December 2020

Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities

1 reference

12 December 2020

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells

1 reference

12 December 2020

Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression

1 reference

12 December 2020

1 reference

12 December 2020

Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors

1 reference

12 December 2020

Neurological complications of HIV infection.

1 reference

12 December 2020

Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS.

1 reference

12 December 2020

Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

1 reference

12 December 2020

The methamphetamine experience: a NIDA partnership

1 reference

12 December 2020

Neurons produce type I interferon during viral encephalitis

1 reference

12 December 2020

Interactions between opioid and chemokine receptors: heterologous desensitization

1 reference

12 December 2020

Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain

1 reference

12 December 2020

Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism

1 reference

12 December 2020

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

1 reference

12 December 2020

Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity

1 reference

12 December 2020

Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress.

1 reference

12 December 2020

Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex.

1 reference

12 December 2020

The AIDS dementia complex: II. Neuropathology.

1 reference

12 December 2020

Neuroscience. Unwrapping glial cells from the synapse: what lies inside?

1 reference

12 December 2020

Neuroendocrine aspects of the response to stress

1 reference

12 December 2020

Opioid G protein-coupled receptors: signals at the crossroads of inflammation

1 reference

12 December 2020

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

1 reference

12 December 2020

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

12 December 2020

Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

1 reference

12 December 2020

Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction

1 reference

12 December 2020

Interferon receptors.

1 reference

12 December 2020

Lineage pathway of human brain progenitor cells identified by JC virus susceptability

1 reference

12 December 2020

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

1 reference

12 December 2020

Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV.

1 reference

12 December 2020

Aging, stress and the hippocampus

1 reference

12 December 2020

Adrenal insufficiency in HIV infection: a review and recommendations

1 reference

12 December 2020

Astroglia induce neurogenesis from adult neural stem cells

1 reference

12 December 2020

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

12 December 2020

CNS immune privilege: hiding in plain sight

1 reference

12 December 2020

Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis

1 reference

12 December 2020

Impact of psychostimulants on vesicular monoamine transporter function

1 reference

12 December 2020

Decreased brain dopaminergic transporters in HIV-associated dementia patients

1 reference

12 December 2020

HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines

1 reference

12 December 2020

Interferon and the central nervous system

1 reference

12 December 2020

Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum

1 reference

12 December 2020

Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures

1 reference

12 December 2020

Molecular basis for interactions of HIV and drugs of abuse.

1 reference

12 December 2020

Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia

1 reference

12 December 2020

Immunoregulatory effects of morphine on human lymphocytes

1 reference

12 December 2020

Interferons and their actions

1 reference

12 December 2020

Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons

1 reference

12 December 2020

Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products

1 reference

12 December 2020

Involvement of dopamine in the progression of AIDS Dementia Complex

1 reference

12 December 2020

Interferon receptors.

1 reference

12 December 2020

Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes

1 reference

12 December 2020

Workshop report: The effects of psychological variables on the progression of HIV-1 disease

1 reference

12 December 2020

Increased glial metabolites predict increased working memory network activation in HIV brain injury

1 reference

12 December 2020

HIV-1 infection and its impact on the HPA axis, cytokines, and cognition

1 reference

12 December 2020

Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

1 reference

12 December 2020

Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells

1 reference

12 December 2020

Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients

1 reference

12 December 2020

Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake

1 reference

12 December 2020

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

1 reference

12 December 2020

Immunosuppressive effects of morphine on immune responses in mice

1 reference

12 December 2020

Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities

1 reference

12 December 2020

Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism

1 reference

12 December 2020

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

12 December 2020

Combined and independent effects of chronic marijuana use and HIV on brain metabolites

1 reference

12 December 2020

HIV tat and neurotoxicity

1 reference

12 December 2020

Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum

1 reference

12 December 2020

Reactive microgliosis

1 reference

12 December 2020

Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys

1 reference

12 December 2020

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

1 reference

12 December 2020

Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.

1 reference

12 December 2020

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

1 reference

12 December 2020

Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.

1 reference

12 December 2020

Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.

1 reference

12 December 2020

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia

1 reference

12 December 2020

Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

1 reference

12 December 2020